Literature DB >> 21741055

The role of impulse control disorders in Tourette syndrome: an exploratory study.

Madeleine C Frank1, John Piedad, Hugh Rickards, Andrea E Cavanna.   

Abstract

INTRODUCTION: Tourette syndrome (TS) is a neurodevelopmental condition characterised by the presence of multiple motor tics and one or more phonic tics, often associated with co-morbid behavioural problems. Impulse control disorders (ICDs) are a set of disorders where patients have significant difficulties in controlling their urges to perform rewarding behaviours. ICDs are expected to be common in patients with TS, as many problems reported in TS are related to difficulties in controlling impulsivity. AIMS: This exploratory study aimed to determine the clinical characteristics of ICDs in adult patients with TS, and to investigate the relationship between the presence of ICDs and health-related quality of life (HR-QOL).
METHODS: Thirty-one patients with a diagnosis of TS were screened for ICDs using the Minnesota Impulsive Disorders Interview (MIDI). HR-QOL was assessed using a generic instrument, the Medical Outcomes Study 36-Item Short-Form Health Survey (SF-36) and a disease-specific scale, the Gilles de la Tourette Syndrome-Quality of Life Scale (GTS-QOL).
RESULTS: Twenty-three out of 31 participants (74.2%) had at least one ICD. The most common ICDs were intermittent explosive disorder (51.6%) and compulsive buying disorder (41.9%). The number of ICDs significantly correlated with reduced HR-QOL (p=0.011) as measured by the GTS-QOL, but not by the SF-36.
CONCLUSIONS: ICDs are common in patients with TS. HR-QOL measures specific to this patient population show that the presence of co-morbid ICDs results in poorer HR-QOL.
Copyright © 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21741055     DOI: 10.1016/j.jns.2011.06.032

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  18 in total

Review 1.  The implication of neuroactive steroids in Tourette's syndrome pathogenesis: A role for 5α-reductase?

Authors:  M Bortolato; R Frau; S C Godar; L J Mosher; S Paba; F Marrosu; P Devoto
Journal:  J Neuroendocrinol       Date:  2013-11       Impact factor: 3.627

2.  Prevalence and predictors of hair pulling disorder and excoriation disorder in Tourette syndrome.

Authors:  Erica Greenberg; Esther S Tung; Caitlin Gauvin; Lisa Osiecki; Kelly G Yang; Erin Curley; Angela Essa; Cornelia Illmann; Paul Sandor; Yves Dion; Gholson J Lyon; Robert A King; Sabrina Darrow; Matthew E Hirschtritt; Cathy L Budman; Marco Grados; David L Pauls; Nancy J Keuthen; Carol A Mathews; Jeremiah M Scharf
Journal:  Eur Child Adolesc Psychiatry       Date:  2017-11-02       Impact factor: 4.785

3.  Tourette syndrome increases risk of bone fractures: a population-based cohort study.

Authors:  Yuan-Yuan Lu; Ming-Yu Wang; I-Hua Wei; Che-Chen Lin; Chih-Chia Huang
Journal:  Eur Child Adolesc Psychiatry       Date:  2016-11-02       Impact factor: 4.785

4.  Comprehensive systematic review summary: Treatment of tics in people with Tourette syndrome and chronic tic disorders.

Authors:  Tamara Pringsheim; Yolanda Holler-Managan; Michael S Okun; Joseph Jankovic; John Piacentini; Andrea E Cavanna; Davide Martino; Kirsten Müller-Vahl; Douglas W Woods; Michael Robinson; Elizabeth Jarvie; Veit Roessner; Maryam Oskoui
Journal:  Neurology       Date:  2019-05-07       Impact factor: 9.910

5.  Deep brain stimulation effect on anterior pallidum reduces motor impulsivity in Parkinson's disease.

Authors:  Khaled Moussawi; Min Jae Kim; Sydney Baybayan; Myles Wood; Kelly A Mills
Journal:  Brain Stimul       Date:  2021-11-05       Impact factor: 8.955

Review 6.  The role of atypical antipsychotics for treatment of Tourette's syndrome: an overview.

Authors:  Cathy L Budman
Journal:  Drugs       Date:  2014-07       Impact factor: 9.546

Review 7.  Animal models of tic disorders: a translational perspective.

Authors:  Sean C Godar; Laura J Mosher; Giuseppe Di Giovanni; Marco Bortolato
Journal:  J Neurosci Methods       Date:  2014-09-20       Impact factor: 2.390

8.  Dopamine agonists and the suppression of impulsive motor actions in Parkinson disease.

Authors:  Scott A Wylie; Daniel O Claassen; Hilde M Huizenga; Kerilyn D Schewel; K Richard Ridderinkhof; Theodore R Bashore; Wery P M van den Wildenberg
Journal:  J Cogn Neurosci       Date:  2012-05-09       Impact factor: 3.225

Review 9.  Neurobiology of the Premonitory Urge in Tourette's Syndrome: Pathophysiology and Treatment Implications.

Authors:  Andrea E Cavanna; Kevin J Black; Mark Hallett; Valerie Voon
Journal:  J Neuropsychiatry Clin Neurosci       Date:  2017-01-25       Impact factor: 2.198

10.  Increased thalamic gamma band activity correlates with symptom relief following deep brain stimulation in humans with Tourette's syndrome.

Authors:  Nicholas Maling; Rowshanak Hashemiyoon; Kelly D Foote; Michael S Okun; Justin C Sanchez
Journal:  PLoS One       Date:  2012-09-06       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.